Cervical cancer is rapidly becoming the most prevalent cancer in Canada, prompting calls from leading medical professionals for immediate governmental intervention. During a recent press conference held in Ottawa, the Society of Gynecologic Oncology of Canada highlighted the pressing need for enhanced measures to combat what they describe as a “silent national health crisis.” This statement comes in the wake of the federal government’s action plan, unveiled in July 2025, which aims to eradicate cervical cancer as a public health concern by 2040.
Alarming Statistics Highlight the Crisis
Dr. Shannon Salvador, president of the Society of Gynecologic Oncology of Canada, expressed grave concerns about the current situation. “Canada is grappling with a silent national health crisis,” she stated. In 2025 alone, approximately 1,650 Canadians are expected to receive a cervical cancer diagnosis, with around 430 succumbing to the disease—an outcome that could largely be prevented.
Dr. Salvador pointed to the stagnation in the uptake of the human papillomavirus (HPV) vaccine as a significant factor in this trend. “While we have relied heavily on Pap testing over the years, the HPV vaccination rates are alarmingly low,” she remarked, noting that the completion rate stands at merely 64 per cent—far short of the threshold necessary for effective elimination.
The Call for Enhanced Screening Methods
To address these shortcomings, the Society is advocating for a national overhaul of cervical cancer screening protocols. Dr. Salvador recommends the immediate adoption of HPV DNA testing and the introduction of self-collection kits, which would facilitate easier access to screening.
Currently, HPV testing is performed through either a cervical swab or a vaginal swab, and self-administered testing is available. The Canadian Cancer Society supports this method, stating that it allows individuals to collect samples from the comfort of their homes. Dr. Salvador emphasised that these kits could significantly lower barriers to access, particularly for individuals facing geographical isolation, past trauma, or lacking a family doctor.
Addressing Disparities in Healthcare Access
The disparities in healthcare access are particularly pronounced among Indigenous populations and those in rural or underserved communities. Dr. Sarah Kean, the provincial lead for cervical cancer in Manitoba, highlighted that Indigenous women often face more severe outcomes due to systemic issues such as geographic isolation and systemic racism within healthcare. “This isn’t a biological issue; it’s a matter of access,” she asserted.
Dr. Kean urges for comprehensive and robust HPV screening across Canada, calling for federal legislation to ensure universal access. “Robust HPV screening must translate to more than mere guideline updates; it requires a commitment to equitable access across all provinces and territories,” she urged.
Financial Implications of Cervical Cancer
The financial burden of cervical cancer on the Canadian healthcare system is substantial. Dr. Salvador noted that the costs associated with treating cervical cancer are projected to reach $132 million in 2024. Conversely, the expense of screening eligible Canadians would total around $106 million over five years.
As the Canadian Cancer Society reported in November 2025, cervical cancer accounts for the fourth highest rate of cancer diagnoses and deaths among females globally. The report indicated a concerning stagnation in progress against this disease, with a slight decrease in incidence rates from 2005 to 2021, indicating that while other cancers are seeing reductions, cervical cancer rates remain stubbornly high.
Why it Matters
The rising incidence of cervical cancer in Canada highlights a critical gap in public health policy and presents an urgent call to action. By improving access to screening and vaccination, particularly for vulnerable populations, Canada can make significant strides toward eliminating this preventable disease. Addressing the systemic barriers and ensuring equitable healthcare access is not only a moral imperative but also a necessary step towards safeguarding the health of all Canadians. As the nation aims to fulfil its commitment to eradicate cervical cancer by 2040, decisive actions taken today will shape the health landscape for generations to come.